Qualigen Therapeutics (QLGN), majority owned by Faraday Future (FFAI), announced that it will rebrand as AIxCrypto following its stockholder meeting on November 12. Following its targeted rebranding on November 12, the company will launch the public beta of its BesTrade DeAI Agent by the end of November and release its EAI RWA Utility Token Whitepaper.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on QLGN:
- Why Is Qualigen Stock (QLGN) Exploding Today? Crypto Deal Sparks the Rally
- Qualigen Therapeutics partners with BitGo to execute C10 treasury allocation
- Qualigen Therapeutics Secures $41M for Crypto Transformation
- Qualigen Therapeutics closes $41M PIPE financing led by Faraday Future
- Qualigen Therapeutics Announces $41M Private Placement